M&A TRANSACTION · 2020
Marley Drug, Inc acquired by Medicure Inc.
$6.3M· 3.7x EBITDA· 0.90x revenue
Target
Marley Drug, Inc
Acquirer
Medicure Inc.
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$7.0M
EBITDA
$1.7M
Deal Value
$6.3M
EV/EBITDA
3.7x
Context
This $6.3M acquisition of Marley Drug, Inc by Medicure Inc. sits in the pharmacy sub-vertical. The 3.7x EBITDA multiple paid in 2020 can be compared against the population median for pharmacy transactions of similar size on our Pharmacy valuation hub. Medicure Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price pharmacy businesses on our Pharmacy strategic buyer-pool page.
Source
Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own pharmacy
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Marley Drug, Inc acquisition.